In addition, Wang's studies indicated that two CD133 miRNA binding site variants, rs2240688 and rs3130, may be potential biomarkers for genetic susceptibility to gastric cancer and possible predictors for survival in gastric cancer patients [26]. This evidence concerns the gene PROM1 and gastric cancer.